Bio-Techne Corp - Common Stock (TECH)
Healthcare › Biological Products, (No Diagnostic Substances)
Price History
Feb 9, 2026 — May 16, 2026Investment Snapshot
- Trading 156% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 7.2% — below-average profitability
- Revenue growing at 5% annually
Bio-Techne Corp - Common Stock (TECH) is a Healthcare company operating in Biological Products, (No Diagnostic Substances), listed on the NASDAQ , with a market capitalisation of $6.8 billion . Key value metrics: P/E ratio 45.2, P/B ratio 3.25, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Bio-Techne Corp - Common Stock — Fundamental Analysis Summary
Bio-Techne Corp - Common Stock (TECH) is currently trading 156% above its Graham Number of $16.93, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 45.2x.
On financial health, TECH shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 7.2% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.21.
StockPik's composite Value Score for TECH is 59/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
TECH reports a high gross margin of 66.3% (sector average: 40.1%) and a solid operating margin of 17.9%.
TECH shows revenue growing at 5% year-over-year, with earnings declining at 56%.
TECH pays a modest dividend yield of 0.7%.